Free Trial

DiaMedica Therapeutics (DMAC) SEC Filings & 10K Form

DiaMedica Therapeutics logo
$6.01 +0.01 (+0.17%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$6.01 0.00 (0.00%)
As of 08/14/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent DiaMedica Therapeutics SEC Filings

DateFilerForm TypeView
08/12/2025
4:27 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
3:15 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
3:17 PM
DiaMedica Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2025
11:15 PM
DiaMedica Therapeutics (Filer)
Form EFFECT
08/06/2025
7:00 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2025
7:30 AM
DiaMedica Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/30/2025
4:31 PM
DiaMedica Therapeutics (Subject)
TomEnterprise AB (Filed by)
Form SCHEDULE 13G/A
07/30/2025
4:33 PM
DiaMedica Therapeutics (Subject)
TRILL AB (Filed by)
Form SCHEDULE 13G/A
07/25/2025
5:54 PM
DiaMedica Therapeutics (Issuer)
STAHLBERG JAN (Reporting)
TRILL AB (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
4:49 PM
DiaMedica Therapeutics (Issuer)
TomEnterprise AB (Reporting)
TomEnterprise Private AB (Reporting)
Von Koch Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:35 PM
DiaMedica Therapeutics (Issuer)
JACINTO RICHARD II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
7:01 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
7:05 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:41 PM
DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
6:35 AM
DiaMedica Therapeutics (Filer)
Form ARS
03/28/2025
6:14 AM
DiaMedica Therapeutics (Filer)
Form DEF 14A
03/28/2025
6:15 AM
DiaMedica Therapeutics (Filer)
Form DEFA14A
03/17/2025
3:30 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
7:30 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
4:06 PM
DiaMedica Therapeutics (Issuer)
O'Connor Daniel J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:46 PM
DiaMedica Therapeutics (Issuer)
Parsons James T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DMAC) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners